The SUCCESS-Trial -toxicity analysis of a phase III study evaluating the role of Docetaxel and Gemcitabine in the adjuvant therapy of breast cancer patients
W. Janni, E. Genss, B. Rack, H. Sommer, M. Rezai, A. Schneider, W. Lichtenegger, M. Beckmann, A. Schneeweiss, K. FrieseVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70554-8
File:
PDF, 73 KB
english, 2008